Rob Shawah | CFO |
Dave Luci | President and CEO |
Ed Arce | HC. Wainwright |
Michael Okunewitch | Maxim Group |
Jim Molloy | Alliance Global Partners |
Greetings, and welcome to the Acurx Pharmaceuticals to discuss Second Quarter 2023 Financial Results and Business Update. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Mr.